Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L
High level of serum lactate dehydrogenase (LDH) is a well-known poor prognostic factor in patients with malignancies. However, there was no data on overall survival (OS) in cancer patients with serum LDH level > 1000 IU/L, and the prognostic value of the changes in LDH over time for OS had not be...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Netherlands
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097084/ |